UNSPSC 85531443: Supplement left femoral vein with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left femoral vein with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UN0KZ

UNSPSC 85531443 Supplement left femoral vein with nonautologous tissue substitute, open approach is a Commodity code whose nominal scope — a specific surgical procedure involving vascular tissue substitution — shows little alignment with recent state and local procurement activity. The six opportunities posted under this code since July 2026 span independent medical evaluation services, surgical benefit carve-outs for PPO plans, occupational medical surveillance, specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing. None involves the procurement or supply of vascular implants, tissue substitutes, or surgical instruments related to femoral vein supplementation. The mismatch suggests the code has been applied to these health-services opportunities in error or that the taxonomy assignment does not reflect the actual goods or services being purchased.

Recent activity appears concentrated among state health systems, county human-resources and benefits functions, and public-safety retirement boards rather than hospital procurement departments or surgical-supply vendors. The Washington State Department of Transportation's ferries division, the City of Phoenix Retirement Office, the City of Long Beach, Harris County Juvenile Probation Department, Collier County Board of Commissioners, and the County of Santa Clara Health System all posted opportunities between late July and mid-September 2026, with response deadlines between September 25 and October 16, 2026. Geographic spread includes Arizona, California, Florida, Texas, and Washington. Given the disconnect between the code's surgical-procedure scope and the administrative and occupational-health services actually being solicited, vendors in surgical implants, tissue banks, or vascular-graft supply should not rely on this code as a reliable source of relevant opportunity intelligence.